{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "regularMarketChangePercent": 3.1351316, "regularMarketPrice": 0.0954, "exchange": "NCM", "shortName": "Aptinyx Inc.", "longName": "Aptinyx Inc.", "messageBoardId": "finmb_336341295", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "firstTradeDateMilliseconds": 1529587800000, "tradeable": false, "cryptoTradeable": false, "priceHint": 4, "regularMarketChange": 0.002899997, "regularMarketTime": 1684180805, "regularMarketDayHigh": 0.0999, "regularMarketDayRange": "0.089 - 0.0999", "regularMarketDayLow": 0.089, "regularMarketVolume": 2172382, "regularMarketPreviousClose": 0.0925, "bid": 0.0, "ask": 0.0, "bidSize": 11, "askSize": 12, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 0.09, "averageDailyVolume3Month": 4428033, "averageDailyVolume10Day": 5132330, "fiftyTwoWeekLowChange": 0.0354, "fiftyTwoWeekLowChangePercent": 0.59000003, "fiftyTwoWeekRange": "0.06 - 0.74", "fiftyTwoWeekHighChange": -0.64460003, "fiftyTwoWeekHighChangePercent": -0.8710811, "fiftyTwoWeekLow": 0.06, "fiftyTwoWeekHigh": 0.74, "earningsTimestamp": 1680206400, "earningsTimestampStart": 1690973940, "earningsTimestampEnd": 1691409600, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.96, "epsForward": -0.44, "epsCurrentYear": -0.47, "priceEpsCurrentYear": -0.20297872, "sharesOutstanding": 67715696, "bookValue": 0.565, "fiftyDayAverage": 0.1286, "fiftyDayAverageChange": -0.033200003, "fiftyDayAverageChangePercent": -0.25816488, "twoHundredDayAverage": 0.3212, "twoHundredDayAverageChange": -0.22580001, "twoHundredDayAverageChangePercent": -0.7029888, "marketCap": 6460077, "forwardPE": -0.21681818, "priceToBook": 0.16884956, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "3.0 - Hold", "displayName": "Aptinyx", "symbol": "APTX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "909 Davis Street", "address2": "Suite 600", "city": "Evanston", "state": "IL", "zip": "60201", "country": "United States", "phone": "847 871 0377", "website": "https://www.aptinyx.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. Its lead product candidate NYX-783, an N-methyl-D-aspartate receptors (NMDAr) modulator that is in Phase I clinical trial to treat opioid use disorder, or OUD; and in preclinical trial for the treatment of alcohol use disorder, or AUD. The company has a research collaboration agreement with Allergan plc. Aptinyx Inc. was incorporated in 2015 and is headquartered in Evanston, Illinois.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Dr. Andrew D. Kidd B.M. B.Ch., M.D.", "age": 46, "title": "Interim Principal Exec. Officer, Principal Financial Officer & Principal Accounting Officer", "yearBorn": 1976, "fiscalYear": 2022, "totalPay": {"raw": 736600, "fmt": "736.6k", "longFmt": "736,600"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Craig R. Jalbert CIRA", "age": 60, "title": "Pres, Treasurer, Corp. Sec. & Director", "yearBorn": 1962, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Patrick  Flavin", "title": "Sr. Mang. of Corp. Devel. & Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Molly  Dir", "title": "VP of HR", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Kathryn  King Ph.D.", "title": "Sr. VP of Clinical & CMC Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Tim  Noffke", "title": "VP of Program Management & Chief of Staff", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Harald  Murck M.D., Ph.D.", "title": "VP of Clinical & Medical Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 8, "boardRisk": 8, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}